Similar Papers

Paper Title
Journal
Date
Author
Efficacy of oral SERDs in the treatment of ER+, HER2− metastatic breast cancer: a stratified analysis of the ESR1 wild type and mutant subgroups
N.Z.H Wong ... S.S Dawood
Annals of Oncology | VOL. -
N.Z.H Wong, et. al.N.Z.H Wong ... S.S Dawood
01 Oct 2023
Abstract OT2-06-02: Phase 2 trial with safety-run in of gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive HER2 negative breast cancer
Sneha Phadke ... Kari Wisinski
Cancer Research | VOL. 80
Sneha Phadke, et. al.Sneha Phadke ... Kari Wisinski
14 Feb 2020
Abstract PS10-40: Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer
Baptiste Porte ... François-Clement Bidard
Cancer Research | VOL. 81
Baptiste Porte, et. al.Baptiste Porte ... François-Clement Bidard
15 Feb 2021
Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL
Marc Thill ... Anja Welt
Cancer Research | VOL. 84
Marc Thill, et. al.Marc Thill ... Anja Welt
02 May 2024
View more papers

More From: EMJ Oncology

Paper Title
Journal
Date
Author
Anti-Mitotic Activity and Downstream Immune Response of Tumor Treating Fields (TTFields) Therapy
European Medical Journal
EMJ Oncology | VOL. -
European Medical Journal European Medical Journal
23 Dec 2024
Elacestrant Monotherapy as a Second-Line Treatment for ER-Positive, HER2-Negative Advanced Breast Cancer with ESR1 Mutations
European Medical Journal
EMJ Oncology | VOL. -
European Medical Journal European Medical Journal
06 Dec 2024
ESR1-Mutation Testing at First Progression in ER-Positive, HER2-Negative Advanced Breast Cancer
European Medical Journal
EMJ Oncology | VOL. -
European Medical Journal European Medical Journal
04 Dec 2024
Effectiveness of Vinorelbine in the Management of Pseudomyogenic Hemangioendothelioma: A Case Report
Safae Toumi ... Sanae Amalik
EMJ Oncology | VOL. -
Safae Toumi, et. al.Safae Toumi ... Sanae Amalik
29 Oct 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.